Pharmacy

The FINANCIAL -- Amgen on October 27 announced financial results for the third quarter of 2016. Key results include:

The FINANCIAL -- Operating profit decreased by 1% reported in local currencies and by 3% in Danish kroner to DKK...

The FINANCIAL -- Sanofi Chief Executive Officer, Olivier Brandicourt, commented:

The FINANCIAL -- Allergan plc on October 26 announced changes to leadership roles within its board of directors.  Effective today,...

The FINANCIAL -- Novo Nordisk on October 25 announced the submission of a supplemental New Drug Application (sNDA) to the...

The FINANCIAL -- The Bayer Group remained on a path of growth in the third quarter of 2016 and took...

The FINANCIAL -- Merck, known as MSD outside the United States and Canada, on October 25 announced financial results for...

The FINANCIAL -- Amgen (Europe) GmbH, an affiliate of Amgen Inc. on October 25 announced an investment in eHealth Ventures,...

The FINANCIAL -- Eli Lilly and Company on October 25 announced financial results for the third quarter of 2016.

The FINANCIAL -- Astellas Pharma Inc. and Pfizer Inc. on October 21 announced the U.S. Food and Drug Administration (FDA)...

The FINANCIAL -- Commenting on the Group’s first nine months, Roche CEO Severin Schwan said: “We had continued good sales...

The FINANCIAL -- Abbott on October 19 announced financial results for the third quarter ended Sept. 30, 2016.

The FINANCIAL -- Allergan plc and Vitae Pharmaceuticals, Inc., a clinical-stage biotechnology company, on October 17 announced that the waiting...

The FINANCIAL -- Pfizer Inc. on October 10 announced results from the Phase 3 S-TRAC clinical trial (Sunitinib Trial as...

The FINANCIAL -- Teva Pharmaceutical Industries Ltd., Celltrion, Inc. and Celltrion Healthcare on October 6 announce that the companies have...